Dr. Aaron Sorrin and researchers at the University of Maryland found a new potential combination therapy for ovarian cancer. This combination includes a novel light-based technology, called photodynamic priming, and a targeted therapeutic against a specific cancer cell receptor, effectively suppressing invasion of cancer cells. Modulight’s scientific board wanted to highlight this research especially because novel therapeutic solutions are urgently needed against this aggressive disease, which despite the best possible current therapies, recurs in most patients leading to a dire prognosis with very few therapeutic options available.

Modulight is very happy to be supporting this research. We would like to deliver our warmest congratulations to the research team!

Modulight products used:

ML6600 series lasers

Read more:

Cancer & Oncology

About Modulight’s LASER-SHARP RESEARCH concept:

Modulight has launched a concept where our scientific board monthly highlights cutting-edge scientific research articles from our customers. Important selection criteria are that Modulight and laser product are mentioned in the publication, the impact and relevance of the results, clinical translatability, as well as scientific quality of the journal. The nominated research groups will be rewarded to encourage the great work done.